234 related articles for article (PubMed ID: 10523795)
1. Micrometastatic bone marrow involvement: detection and prognostic significance.
Braun S; Pantel K
Med Oncol; 1999 Sep; 16(3):154-65. PubMed ID: 10523795
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of micrometastatic bone marrow involvement.
Braun S; Pantel K
Breast Cancer Res Treat; 1998; 52(1-3):201-16. PubMed ID: 10066083
[TBL] [Abstract][Full Text] [Related]
3. Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow.
Zippelius A; Kufer P; Honold G; Köllermann MW; Oberneder R; Schlimok G; Riethmüller G; Pantel K
J Clin Oncol; 1997 Jul; 15(7):2701-8. PubMed ID: 9215843
[TBL] [Abstract][Full Text] [Related]
4. Micrometastatic breast cancer cells in bone marrow at primary surgery: prognostic value in comparison with nodal status.
Diel IJ; Kaufmann M; Costa SD; Holle R; von Minckwitz G; Solomayer EF; Kaul S; Bastert G
J Natl Cancer Inst; 1996 Nov; 88(22):1652-8. PubMed ID: 8931609
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of occult metastatic cells in bone marrow of breast cancer patients.
Braun S; Pantel K
Oncologist; 2001; 6(2):125-32. PubMed ID: 11306724
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibody therapy with edrecolomab in breast cancer patients: monitoring of elimination of disseminated cytokeratin-positive tumor cells in bone marrow.
Braun S; Hepp F; Kentenich CR; Janni W; Pantel K; Riethmüller G; Willgeroth F; Sommer HL
Clin Cancer Res; 1999 Dec; 5(12):3999-4004. PubMed ID: 10632331
[TBL] [Abstract][Full Text] [Related]
7. [Micrometastatic cells in the bone marrow of patients with breast carcinoma].
Diel IJ; Solomayer EF; Bastert G
Radiologe; 2000 Aug; 40(8):681-7. PubMed ID: 11006937
[TBL] [Abstract][Full Text] [Related]
8. Methodological analysis of immunocytochemical screening for disseminated epithelial tumor cells in bone marrow.
Pantel K; Schlimok G; Angstwurm M; Weckermann D; Schmaus W; Gath H; Passlick B; Izbicki JR; Riethmüller G
J Hematother; 1994; 3(3):165-73. PubMed ID: 7530132
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of an increased number of micrometastatic tumor cells in the bone marrow of patients with first recurrence of breast carcinoma.
Janni W; Gastroph S; Hepp F; Kentenich C; Rjosk D; Schindlbeck C; Dimpfl T; Sommer H; Braun S
Cancer; 2000 May; 88(10):2252-9. PubMed ID: 10820346
[TBL] [Abstract][Full Text] [Related]
10. Comparative analysis of micrometastasis to the bone marrow and lymph nodes of node-negative breast cancer patients receiving no adjuvant therapy.
Braun S; Cevatli BS; Assemi C; Janni W; Kentenich CR; Schindlbeck C; Rjosk D; Hepp F
J Clin Oncol; 2001 Mar; 19(5):1468-75. PubMed ID: 11230493
[TBL] [Abstract][Full Text] [Related]
11. Micrometastases in bone marrow: prognostic indicators for pancreatic cancer.
Roder JD; Thorban S; Pantel K; Siewert JR
World J Surg; 1999 Sep; 23(9):888-91. PubMed ID: 10449815
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of hematogenous dissemination and biological profile of the tumor in early breast cancer patients: a prospective observational study.
Solá M; Margelí M; Castellá E; Julian JF; Rull M; Gubern JM; Mariscal A; Barnadas A; Fraile M
BMC Cancer; 2011 Jun; 11():252. PubMed ID: 21679400
[TBL] [Abstract][Full Text] [Related]
13. Clinical relevance of occult metastatic cells in the bone marrow of patients with different stages of breast cancer.
Janni W; Rjosk D; Braun S
Clin Breast Cancer; 2000 Oct; 1(3):217-25. PubMed ID: 11899646
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of immunocytochemical detection of tumor cells using digital microscopy in peripheral blood and bone marrow of breast cancer patients.
Pierga JY; Bonneton C; Vincent-Salomon A; de Cremoux P; Nos C; Blin N; Pouillart P; Thiery JP; Magdelénat H
Clin Cancer Res; 2004 Feb; 10(4):1392-400. PubMed ID: 14977842
[TBL] [Abstract][Full Text] [Related]
15. Reduction of metastatic carcinoma cells in bone marrow by intravenously administered monoclonal antibody: towards a novel surrogate test to monitor adjuvant therapies of solid tumours.
Schlimok G; Pantel K; Loibner H; Fackler-Schwalbe I; Riethmüller G
Eur J Cancer; 1995 Oct; 31A(11):1799-803. PubMed ID: 8541104
[TBL] [Abstract][Full Text] [Related]
16. The value of bone marrow aspirates culture for the detection of bone marrow micrometastasis in breast cancer.
Loo WT; Fong JH; Zhu L; Cheung MN; Chow LW
Biomed Pharmacother; 2005 Oct; 59 Suppl 2():S384-6. PubMed ID: 16507415
[TBL] [Abstract][Full Text] [Related]
17. Immunomagnetic enrichment and detection of isolated tumor cells in bone marrow of patients with epithelial malignancies.
Weihrauch MR; Skibowski E; Draube A; Geller A; Tesch H; Diehl V; Bohlen H
Clin Exp Metastasis; 2002; 19(7):617-21. PubMed ID: 12498391
[TBL] [Abstract][Full Text] [Related]
18. Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells.
Fehm T; Hoffmann O; Aktas B; Becker S; Solomayer EF; Wallwiener D; Kimmig R; Kasimir-Bauer S
Breast Cancer Res; 2009; 11(4):R59. PubMed ID: 19664291
[TBL] [Abstract][Full Text] [Related]
19. Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cells.
Pantel K; Schlimok G; Braun S; Kutter D; Lindemann F; Schaller G; Funke I; Izbicki JR; Riethmüller G
J Natl Cancer Inst; 1993 Sep; 85(17):1419-24. PubMed ID: 7688814
[TBL] [Abstract][Full Text] [Related]
20. Bone marrow and lymph node assessment for minimal residual disease in patients with breast cancer.
Diel IJ; Cote RJ
Cancer Treat Rev; 2000 Feb; 26(1):53-65. PubMed ID: 10660491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
